Literature DB >> 33920045

Morphological and Molecular Characterization of Proliferative Inflammatory Atrophy in Canine Prostatic Samples.

Giovana de Godoy Fernandes1, Bruna Pedrina1, Patrícia de Faria Lainetti1, Priscila Emiko Kobayashi1, Verônica Mollica Govoni1, Chiara Palmieri2, Veridiana Maria Brianezi Dignani de Moura3, Renée Laufer-Amorim1, Carlos Eduardo Fonseca-Alves1,4.   

Abstract

Proliferative inflammatory atrophy (PIA) is an atrophic lesion of the prostate gland that occurs in men and dogs and is associated with a chronic inflammatory infiltrate. In this study, we retrospectively reviewed canine prostatic samples from intact dogs, identifying 50 normal prostates, 140 cases of prostatic hyperplasia, 171 cases of PIA, 84 with prostate cancer (PC), 14 with prostatic intraepithelial neoplasia (PIN) and 10 with bacterial prostatitis. PIA samples were then selected and classified according to the human classification. The presence of PIA lesions surrounding neoplastic areas was then evaluated to establish a morphological transition from normal to preneoplastic and neoplastic tissue. In addition, the expression of PTEN, P53, MDM2 and nuclear androgen receptor (AR) were analyzed in 20 normal samples and 20 PIA lesions by immunohistochemistry and qPCR. All PIA lesions showed variable degrees of mononuclear cell infiltration around the glands and simple atrophy was the most common histopathological feature. PIA was identified between normal glands and PC in 51 (61%) out of the 84 PC samples. PIA lesions were diffusely positive for molecular weight cytokeratin (HMWC). Decreased PTEN and AR gene and protein expression was found in PIA compared to normal samples. Overall, our results strongly suggest that PIA is a frequent lesion associated with PC. Additionally, this finding corroborates the hypothesis that in dogs, as is the case in humans, PIA is a pre neoplastic lesion that has the potential to progress into PC, indicating an alternative mechanism of prostate cancer development in dogs.

Entities:  

Keywords:  comparative oncology; dog; inflammation; preneoplastic lesion; prostatic atrophy

Year:  2021        PMID: 33920045     DOI: 10.3390/cancers13081887

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  5 in total

Review 1.  A Review on Canine and Feline Prostate Pathology.

Authors:  Chiara Palmieri; Carlos Eduardo Fonseca-Alves; Renee Laufer-Amorim
Journal:  Front Vet Sci       Date:  2022-05-26

Review 2.  Comparative Pathobiology of Canine and Human Prostate Cancer: State of the Art and Future Directions.

Authors:  Eduardo de Paula Nascente; Renée Laufer Amorim; Carlos Eduardo Fonseca-Alves; Veridiana Maria Brianezi Dignani de Moura
Journal:  Cancers (Basel)       Date:  2022-05-31       Impact factor: 6.575

3.  P-Glycoprotein and Androgen Receptor Expression Reveals Independence of Canine Prostate Cancer from Androgen Hormone Stimulation.

Authors:  Alexandre Matheus Baesso Cavalca; Andressa Brandi; Ricardo Henrique Fonseca-Alves; Renée Laufer-Amorim; Carlos Eduardo Fonseca-Alves
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

4.  Urological Cancer Panorama in the Second Year of the COVID-19 Pandemic.

Authors:  Estibaliz López-Fernández; Javier C Angulo; José I López; Claudia Manini
Journal:  Cancers (Basel)       Date:  2022-01-19       Impact factor: 6.639

5.  Fibronectin Modulates the Expression of miRNAs in Prostate Cancer Cell Lines.

Authors:  Bruno Martinucci; Maira Smaniotto Cucielo; Brenda Carvalho Minatel; Sarah Santiloni Cury; Gabriel Henrique Caxali; Mirian Carolini Esgoti Aal; Sergio Luis Felisbino; Danillo Pinhal; Robson Francisco Carvalho; Flávia Karina Delella
Journal:  Front Vet Sci       Date:  2022-07-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.